ストックスクリーナーアプリを入手
3.36
1.47%
-0.05
プレマーケット:
3.50
0.14
+4.17%
前日終値:
$3.41
開ける：
$3.45
24時間の取引高:
479.76K
Relative Volume:
0.34
時価総額：
$311.38M
収益：
-
当期純損益:
$-39.95M
株価収益率:
-7.2274
EPS:
-0.4649
ネットキャッシュフロー:
$-34.08M
1週間 パフォーマンス:
-0.30%
1か月 パフォーマンス:
+12.37%
6か月 パフォーマンス:
-54.04%
1年 パフォーマンス:
-62.29%
1日の値動き範囲:
$3.33
$3.49
1週間の範囲:
$3.23
$3.50
52週間の値動き範囲:
$2.61
$13.99
Anavex Life Sciences Corp Stock (AVXL) Company Profile
Compare AVXL vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corp
|
3.36 | 316.01M | 0 | -39.95M | -34.08M | -0.4649 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Anavex Life Sciences Corp Stock (AVXL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-12-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | 開始されました | Berenberg | Buy |
| 2021-09-23 | 開始されました | BTIG Research | Buy |
| 2020-12-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-28 | 開始されました | Ladenburg Thalmann | Buy |
| 2020-02-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-06-18 | 開始されました | Janney | Buy |
| 2018-05-16 | 再開されました | Maxim Group | Buy |
| 2018-03-08 | 開始されました | ROTH Capital | Buy |
| 2018-02-13 | 繰り返されました | Maxim Group | Buy |
| 2017-09-29 | 再開されました | Noble Financial | Buy |
| 2017-02-07 | 開始されました | Noble Financial | Buy |
| 2016-03-29 | 開始されました | FBR Capital | Outperform |
すべてを表示
Anavex Life Sciences Corp (AVXL) 最新ニュース
H.C. Wainwright initiates Anavex Life Sciences stock with buy rating - Investing.com
H.C. Wainwright initiates Anavex Life Sciences stock with buy rating By Investing.com - Investing.com Canada
MSN Money - MSN
Director Axel Paeger files initial Form 3 for Anavex (AVXL) - Stock Titan
AVXL Stock Price, Quote & Chart | ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) - ChartMill
Anavex Life Sciences (NASDAQ:AVXL) Share Price Passes Below 200 Day Moving AverageTime to Sell? - MarketBeat
AVXL stock soars after Anavex’s new data suggests its Alzheimer’s drug may slow brain shrinkage - MSN
Anavex asks EMA to re-examine its negative opinion on blarcamesine for Alzheimer's - MSN
Anavex stock slides after hours on EMA panel’s negative Alzheimer’s drug opinion — retail traders talk buyout potential - MSN
What Makes Anavex Life Sciences (AVXL) One of the Best Shorted Penny Stocks - Yahoo Finance
Top 5 Trending Stocks On Stocktwits Today: Webull, SharpLink, Anavex Life Sciences, BigBear.ai, And Oscar Health - MSN
Anavex Life Sciences (NASDAQ:AVXL) Share Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Anavex (AVXL) Stock: Buy or Sell? (+7.06%) 2026-04-18High Interest Stocks - Xã Vĩnh Công
AVXL | Anavex Life Sciences Insider Trading - Quiver Quantitative
Anavex Life Sciences Highlights New Scientific Findings on Shared Biology between Autism and Alzheimer's disease - marketscreener.com
Anavex Life Sciences Teases New Pivotal Blarcamesine Trials, Maps Regulatory Path at Needham Conference - MarketBeat
Anavex Life Sciences Advances Blarcamesine Research, Highlighting Shared Autophagy Mechanisms in Autism and Alzheimer’s Disease - Quiver Quantitative
Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease - marketscreener.com
Autistic adults had up to 8x dementia rates in research Anavex cites - Stock Titan
Anavex links autism and Alzheimer’s via autophagy dysfunction - Investing.com
Investors in Anavex Life Sciences Corporation Should Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire
Aug Rallies: Does Anavex Life Sciences Corp have strong fundamentalsMarket Activity Summary & Reliable Momentum Entry Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Anavex Life Sciences Corp. (AVXL) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Anavex Life Sciences Corp. (AVXL) And Encourages Shareholders to Connect - ACCESS Newswire
AVXL Technical Analysis | Trend, Signals & Chart Patterns | ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) - ChartMill
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Anavex Life Sciences Corp. (AVXL) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
AVXL Q1 2026 Earnings: Anavex Life Sciences beats EPS ests, no revenueConsensus Forecast - UBND thành phố Hải Phòng
Aug Retail: Is Anavex Life Sciences Corp stock trending bullish2026 Short Interest & Reliable Volume Spike Alerts - baoquankhu1.vn
Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference - The Manila Times
Anavex Life Sciences Corp. to Present at 25th Annual Needham Virtual Healthcare Conference - Quiver Quantitative
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Anavex Life Sciences Corp. (AVXL) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Anavex Life Sciences Corp. (AVXL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-04-05 | Anavex Life Sciences Corp. (AVXL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:AVXL | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Is Investigating Anavex Life Sciences Corp. (AVXL) And Encourages Investors to Connect - ACCESS Newswire
Anavex Life Sciences Corp. (AVXL) stock price, news, quote and history - Yahoo Finance UK
2026-04-03 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Anavex Life Sciences Corp. (AVXL) And Encourages Investors to Connect | NDAQ:AVXL | Press Release - stockhouse.com
3 Promising Penny Stocks With At Least $200M Market Cap - Sahm
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 635% Upside in Biotechnology - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Encourages Anavex Life Sciences Corp. (AVXL) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Anavex Life Sciences Corp (12X1.HM) Recent Insider Transactions - Yahoo! Finance Canada
AVXL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Anavex Life Sciences' (AVXL) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat
Anavex Life Sciences Provides Comprehensive Regulatory Update - The Manila Times
After withdrawing its EU filing, Anavex keeps Alzheimer’s drug in talks - Stock Titan
Anavex Life Sciences Corp (AVXL) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):